A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency

Clinical trial NCT00389324 · COMPLETED

Trial details

NCT number: NCT00389324
Sponsor: Grifols Therapeutics LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Immunologic Deficiency Syndrome

Start date: 2006-11-01
Primary completion: 2008-08-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.